nodes	percent_of_prediction	percent_of_DWPC	metapath
Cimetidine—FMO1—Vandetanib—thyroid cancer	0.407	0.477	CbGbCtD
Cimetidine—FMO3—Vandetanib—thyroid cancer	0.254	0.298	CbGbCtD
Cimetidine—ABCB11—Doxorubicin—thyroid cancer	0.0355	0.0416	CbGbCtD
Cimetidine—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0205	0.0241	CbGbCtD
Cimetidine—CYP3A7—Sorafenib—thyroid cancer	0.0205	0.0241	CbGbCtD
Cimetidine—CYP3A5—Sorafenib—thyroid cancer	0.0154	0.0181	CbGbCtD
Cimetidine—CYP2C8—Sorafenib—thyroid cancer	0.0148	0.0174	CbGbCtD
Cimetidine—CYP2C19—Sorafenib—thyroid cancer	0.0124	0.0146	CbGbCtD
Cimetidine—CYP1A2—Sorafenib—thyroid cancer	0.0115	0.0134	CbGbCtD
Cimetidine—CYP2C9—Sorafenib—thyroid cancer	0.0103	0.0121	CbGbCtD
Cimetidine—ABCB1—Sorafenib—thyroid cancer	0.01	0.0118	CbGbCtD
Cimetidine—CYP3A4—Vandetanib—thyroid cancer	0.00996	0.0117	CbGbCtD
Cimetidine—CYP2D6—Sorafenib—thyroid cancer	0.00944	0.0111	CbGbCtD
Cimetidine—ABCB1—Doxorubicin—thyroid cancer	0.00608	0.00713	CbGbCtD
Cimetidine—CYP3A4—Sorafenib—thyroid cancer	0.006	0.00704	CbGbCtD
Cimetidine—CYP2D6—Doxorubicin—thyroid cancer	0.00573	0.00672	CbGbCtD
Cimetidine—Allergic cutaneous angiitis—Sorafenib—thyroid cancer	0.00464	0.0545	CcSEcCtD
Cimetidine—White blood cell count decreased—Vandetanib—thyroid cancer	0.00439	0.0516	CcSEcCtD
Cimetidine—SLC22A4—larynx—thyroid cancer	0.00432	0.193	CbGeAlD
Cimetidine—CYP3A4—Doxorubicin—thyroid cancer	0.00364	0.00427	CbGbCtD
Cimetidine—Leukocytoclastic vasculitis—Sorafenib—thyroid cancer	0.00301	0.0353	CcSEcCtD
Cimetidine—Tubulointerstitial nephritis—Vandetanib—thyroid cancer	0.00286	0.0335	CcSEcCtD
Cimetidine—Alopecia reversible—Epirubicin—thyroid cancer	0.0024	0.0282	CcSEcCtD
Cimetidine—Alopecia reversible—Doxorubicin—thyroid cancer	0.00222	0.0261	CcSEcCtD
Cimetidine—Tubulointerstitial nephritis—Sorafenib—thyroid cancer	0.00193	0.0226	CcSEcCtD
Cimetidine—Blood creatinine increased—Vandetanib—thyroid cancer	0.00149	0.0175	CcSEcCtD
Cimetidine—Pancreatitis—Vandetanib—thyroid cancer	0.00135	0.0158	CcSEcCtD
Cimetidine—FMO1—trachea—thyroid cancer	0.00132	0.0593	CbGeAlD
Cimetidine—Gynaecomastia—Sorafenib—thyroid cancer	0.00132	0.0155	CcSEcCtD
Cimetidine—Neutropenia—Vandetanib—thyroid cancer	0.00128	0.0151	CcSEcCtD
Cimetidine—Pneumonia—Vandetanib—thyroid cancer	0.00123	0.0144	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00121	0.0142	CcSEcCtD
Cimetidine—Renal failure—Vandetanib—thyroid cancer	0.0012	0.0141	CcSEcCtD
Cimetidine—Hepatic failure—Sorafenib—thyroid cancer	0.00119	0.014	CcSEcCtD
Cimetidine—SLC22A4—neck—thyroid cancer	0.00115	0.0513	CbGeAlD
Cimetidine—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00113	0.0133	CcSEcCtD
Cimetidine—Bradycardia—Vandetanib—thyroid cancer	0.00112	0.0131	CcSEcCtD
Cimetidine—FMO1—thyroid gland—thyroid cancer	0.00105	0.0469	CbGeAlD
Cimetidine—Erythema multiforme—Vandetanib—thyroid cancer	0.00104	0.0122	CcSEcCtD
Cimetidine—Alopecia—Vandetanib—thyroid cancer	0.00097	0.0114	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.000964	0.0113	CcSEcCtD
Cimetidine—FMO1—head—thyroid cancer	0.000929	0.0416	CbGeAlD
Cimetidine—Pancreatitis—Sorafenib—thyroid cancer	0.000907	0.0107	CcSEcCtD
Cimetidine—FMO3—thyroid gland—thyroid cancer	0.000905	0.0406	CbGeAlD
Cimetidine—Neutropenia—Sorafenib—thyroid cancer	0.000865	0.0102	CcSEcCtD
Cimetidine—Erectile dysfunction—Sorafenib—thyroid cancer	0.000852	0.01	CcSEcCtD
Cimetidine—Pneumonia—Sorafenib—thyroid cancer	0.00083	0.00974	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.000818	0.0096	CcSEcCtD
Cimetidine—Arthralgia—Vandetanib—thyroid cancer	0.000814	0.00955	CcSEcCtD
Cimetidine—SLC22A3—saliva-secreting gland—thyroid cancer	0.000813	0.0364	CbGeAlD
Cimetidine—Renal failure—Sorafenib—thyroid cancer	0.000811	0.00952	CcSEcCtD
Cimetidine—Anxiety—Vandetanib—thyroid cancer	0.000811	0.00952	CcSEcCtD
Cimetidine—Bone marrow depression—Epirubicin—thyroid cancer	0.000808	0.00948	CcSEcCtD
Cimetidine—FMO3—head—thyroid cancer	0.000803	0.036	CbGeAlD
Cimetidine—Thrombocytopenia—Vandetanib—thyroid cancer	0.000764	0.00897	CcSEcCtD
Cimetidine—Bone marrow depression—Doxorubicin—thyroid cancer	0.000747	0.00877	CcSEcCtD
Cimetidine—HRH2—head—thyroid cancer	0.000715	0.032	CbGeAlD
Cimetidine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000711	0.00834	CcSEcCtD
Cimetidine—Erythema multiforme—Sorafenib—thyroid cancer	0.0007	0.00822	CcSEcCtD
Cimetidine—SLC22A4—trachea—thyroid cancer	0.000689	0.0309	CbGeAlD
Cimetidine—Fatigue—Vandetanib—thyroid cancer	0.000673	0.0079	CcSEcCtD
Cimetidine—Constipation—Vandetanib—thyroid cancer	0.000667	0.00783	CcSEcCtD
Cimetidine—Alopecia—Sorafenib—thyroid cancer	0.000655	0.00768	CcSEcCtD
Cimetidine—FMO1—lymph node—thyroid cancer	0.000651	0.0291	CbGeAlD
Cimetidine—Liver injury—Epirubicin—thyroid cancer	0.000648	0.00761	CcSEcCtD
Cimetidine—SLC47A1—thyroid gland—thyroid cancer	0.000622	0.0279	CbGeAlD
Cimetidine—Body temperature increased—Vandetanib—thyroid cancer	0.000617	0.00724	CcSEcCtD
Cimetidine—Liver injury—Doxorubicin—thyroid cancer	0.000599	0.00704	CcSEcCtD
Cimetidine—SLC22A5—saliva-secreting gland—thyroid cancer	0.000591	0.0265	CbGeAlD
Cimetidine—Leukopenia—Sorafenib—thyroid cancer	0.000577	0.00678	CcSEcCtD
Cimetidine—FMO3—lymph node—thyroid cancer	0.000562	0.0252	CbGeAlD
Cimetidine—Atrioventricular block—Epirubicin—thyroid cancer	0.000562	0.0066	CcSEcCtD
Cimetidine—Asthenia—Vandetanib—thyroid cancer	0.00056	0.00657	CcSEcCtD
Cimetidine—SLC47A1—head—thyroid cancer	0.000552	0.0247	CbGeAlD
Cimetidine—Musculoskeletal pain—Epirubicin—thyroid cancer	0.000552	0.00648	CcSEcCtD
Cimetidine—Myalgia—Sorafenib—thyroid cancer	0.000549	0.00644	CcSEcCtD
Cimetidine—Arthralgia—Sorafenib—thyroid cancer	0.000549	0.00644	CcSEcCtD
Cimetidine—SLC22A4—thyroid gland—thyroid cancer	0.000545	0.0244	CbGeAlD
Cimetidine—Diarrhoea—Vandetanib—thyroid cancer	0.000534	0.00627	CcSEcCtD
Cimetidine—Anaphylactic shock—Sorafenib—thyroid cancer	0.000526	0.00618	CcSEcCtD
Cimetidine—Atrioventricular block—Doxorubicin—thyroid cancer	0.00052	0.0061	CcSEcCtD
Cimetidine—Dizziness—Vandetanib—thyroid cancer	0.000516	0.00606	CcSEcCtD
Cimetidine—Thrombocytopenia—Sorafenib—thyroid cancer	0.000515	0.00605	CcSEcCtD
Cimetidine—Aplastic anaemia—Epirubicin—thyroid cancer	0.000512	0.00601	CcSEcCtD
Cimetidine—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.000511	0.00599	CcSEcCtD
Cimetidine—HRH2—lymph node—thyroid cancer	0.000501	0.0224	CbGeAlD
Cimetidine—SLC22A3—thyroid gland—thyroid cancer	0.000496	0.0222	CbGeAlD
Cimetidine—Vomiting—Vandetanib—thyroid cancer	0.000496	0.00582	CcSEcCtD
Cimetidine—Rash—Vandetanib—thyroid cancer	0.000492	0.00577	CcSEcCtD
Cimetidine—Dermatitis—Vandetanib—thyroid cancer	0.000491	0.00577	CcSEcCtD
Cimetidine—Headache—Vandetanib—thyroid cancer	0.000489	0.00574	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000479	0.00563	CcSEcCtD
Cimetidine—Aplastic anaemia—Doxorubicin—thyroid cancer	0.000474	0.00556	CcSEcCtD
Cimetidine—Nausea—Vandetanib—thyroid cancer	0.000463	0.00544	CcSEcCtD
Cimetidine—SLC22A1—head—thyroid cancer	0.00046	0.0206	CbGeAlD
Cimetidine—SLC22A5—trachea—thyroid cancer	0.000456	0.0204	CbGeAlD
Cimetidine—Fatigue—Sorafenib—thyroid cancer	0.000454	0.00533	CcSEcCtD
Cimetidine—Constipation—Sorafenib—thyroid cancer	0.00045	0.00528	CcSEcCtD
Cimetidine—Hepatic failure—Epirubicin—thyroid cancer	0.00044	0.00517	CcSEcCtD
Cimetidine—SLC22A3—head—thyroid cancer	0.00044	0.0197	CbGeAlD
Cimetidine—SLC22A8—head—thyroid cancer	0.000423	0.019	CbGeAlD
Cimetidine—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000419	0.00492	CcSEcCtD
Cimetidine—Body temperature increased—Sorafenib—thyroid cancer	0.000416	0.00488	CcSEcCtD
Cimetidine—Renal impairment—Epirubicin—thyroid cancer	0.000416	0.00488	CcSEcCtD
Cimetidine—Hepatic failure—Doxorubicin—thyroid cancer	0.000407	0.00478	CcSEcCtD
Cimetidine—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000388	0.00456	CcSEcCtD
Cimetidine—Hypersensitivity—Sorafenib—thyroid cancer	0.000388	0.00455	CcSEcCtD
Cimetidine—SLC47A1—lymph node—thyroid cancer	0.000386	0.0173	CbGeAlD
Cimetidine—Renal impairment—Doxorubicin—thyroid cancer	0.000385	0.00452	CcSEcCtD
Cimetidine—Asthenia—Sorafenib—thyroid cancer	0.000378	0.00443	CcSEcCtD
Cimetidine—Blood creatinine increased—Epirubicin—thyroid cancer	0.000371	0.00435	CcSEcCtD
Cimetidine—SLC22A5—thyroid gland—thyroid cancer	0.000361	0.0162	CbGeAlD
Cimetidine—Diarrhoea—Sorafenib—thyroid cancer	0.00036	0.00423	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000356	0.00418	CcSEcCtD
Cimetidine—Dizziness—Sorafenib—thyroid cancer	0.000348	0.00409	CcSEcCtD
Cimetidine—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000343	0.00403	CcSEcCtD
Cimetidine—SLC22A4—lymph node—thyroid cancer	0.000339	0.0152	CbGeAlD
Cimetidine—Pancreatitis—Epirubicin—thyroid cancer	0.000335	0.00394	CcSEcCtD
Cimetidine—Vomiting—Sorafenib—thyroid cancer	0.000335	0.00393	CcSEcCtD
Cimetidine—Rash—Sorafenib—thyroid cancer	0.000332	0.0039	CcSEcCtD
Cimetidine—Dermatitis—Sorafenib—thyroid cancer	0.000332	0.00389	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00033	0.00387	CcSEcCtD
Cimetidine—Headache—Sorafenib—thyroid cancer	0.00033	0.00387	CcSEcCtD
Cimetidine—CYP1A2—thyroid gland—thyroid cancer	0.000327	0.0146	CbGeAlD
Cimetidine—Pancytopenia—Epirubicin—thyroid cancer	0.000325	0.00381	CcSEcCtD
Cimetidine—Neutropenia—Epirubicin—thyroid cancer	0.00032	0.00375	CcSEcCtD
Cimetidine—Nausea—Sorafenib—thyroid cancer	0.000313	0.00367	CcSEcCtD
Cimetidine—Pancreatitis—Doxorubicin—thyroid cancer	0.00031	0.00364	CcSEcCtD
Cimetidine—SLC22A3—lymph node—thyroid cancer	0.000308	0.0138	CbGeAlD
Cimetidine—Pneumonia—Epirubicin—thyroid cancer	0.000307	0.0036	CcSEcCtD
Cimetidine—Drowsiness—Epirubicin—thyroid cancer	0.000305	0.00358	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000302	0.00355	CcSEcCtD
Cimetidine—Pancytopenia—Doxorubicin—thyroid cancer	0.000301	0.00353	CcSEcCtD
Cimetidine—Renal failure—Epirubicin—thyroid cancer	0.0003	0.00352	CcSEcCtD
Cimetidine—Neutropenia—Doxorubicin—thyroid cancer	0.000296	0.00347	CcSEcCtD
Cimetidine—CYP2E1—thyroid gland—thyroid cancer	0.000294	0.0132	CbGeAlD
Cimetidine—Agranulocytosis—Epirubicin—thyroid cancer	0.000285	0.00334	CcSEcCtD
Cimetidine—Pneumonia—Doxorubicin—thyroid cancer	0.000284	0.00333	CcSEcCtD
Cimetidine—Drowsiness—Doxorubicin—thyroid cancer	0.000282	0.00331	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00028	0.00328	CcSEcCtD
Cimetidine—Bradycardia—Epirubicin—thyroid cancer	0.000279	0.00327	CcSEcCtD
Cimetidine—Renal failure—Doxorubicin—thyroid cancer	0.000277	0.00326	CcSEcCtD
Cimetidine—Hepatitis—Epirubicin—thyroid cancer	0.000274	0.00321	CcSEcCtD
Cimetidine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000263	0.00309	CcSEcCtD
Cimetidine—CYP2E1—head—thyroid cancer	0.000261	0.0117	CbGeAlD
Cimetidine—Erythema multiforme—Epirubicin—thyroid cancer	0.000259	0.00304	CcSEcCtD
Cimetidine—Bradycardia—Doxorubicin—thyroid cancer	0.000258	0.00303	CcSEcCtD
Cimetidine—Hepatitis—Doxorubicin—thyroid cancer	0.000253	0.00297	CcSEcCtD
Cimetidine—Alopecia—Epirubicin—thyroid cancer	0.000242	0.00284	CcSEcCtD
Cimetidine—Erythema multiforme—Doxorubicin—thyroid cancer	0.000239	0.00281	CcSEcCtD
Cimetidine—Flatulence—Epirubicin—thyroid cancer	0.000235	0.00276	CcSEcCtD
Cimetidine—SLC22A5—lymph node—thyroid cancer	0.000224	0.01	CbGeAlD
Cimetidine—Alopecia—Doxorubicin—thyroid cancer	0.000224	0.00263	CcSEcCtD
Cimetidine—Agitation—Epirubicin—thyroid cancer	0.000219	0.00257	CcSEcCtD
Cimetidine—Flatulence—Doxorubicin—thyroid cancer	0.000217	0.00255	CcSEcCtD
Cimetidine—Malaise—Epirubicin—thyroid cancer	0.000215	0.00252	CcSEcCtD
Cimetidine—Leukopenia—Epirubicin—thyroid cancer	0.000213	0.0025	CcSEcCtD
Cimetidine—ABCB1—trachea—thyroid cancer	0.000212	0.00948	CbGeAlD
Cimetidine—CYP2D6—head—thyroid cancer	0.000206	0.00925	CbGeAlD
Cimetidine—Myalgia—Epirubicin—thyroid cancer	0.000203	0.00238	CcSEcCtD
Cimetidine—Arthralgia—Epirubicin—thyroid cancer	0.000203	0.00238	CcSEcCtD
Cimetidine—Agitation—Doxorubicin—thyroid cancer	0.000203	0.00238	CcSEcCtD
Cimetidine—Anxiety—Epirubicin—thyroid cancer	0.000202	0.00237	CcSEcCtD
Cimetidine—Malaise—Doxorubicin—thyroid cancer	0.000199	0.00233	CcSEcCtD
Cimetidine—Leukopenia—Doxorubicin—thyroid cancer	0.000197	0.00232	CcSEcCtD
Cimetidine—Confusional state—Epirubicin—thyroid cancer	0.000196	0.0023	CcSEcCtD
Cimetidine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000194	0.00228	CcSEcCtD
Cimetidine—Thrombocytopenia—Epirubicin—thyroid cancer	0.00019	0.00224	CcSEcCtD
Cimetidine—Tachycardia—Epirubicin—thyroid cancer	0.00019	0.00223	CcSEcCtD
Cimetidine—Myalgia—Doxorubicin—thyroid cancer	0.000188	0.0022	CcSEcCtD
Cimetidine—Arthralgia—Doxorubicin—thyroid cancer	0.000188	0.0022	CcSEcCtD
Cimetidine—Anxiety—Doxorubicin—thyroid cancer	0.000187	0.0022	CcSEcCtD
Cimetidine—Confusional state—Doxorubicin—thyroid cancer	0.000181	0.00213	CcSEcCtD
Cimetidine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00018	0.00211	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000177	0.00208	CcSEcCtD
Cimetidine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000176	0.00207	CcSEcCtD
Cimetidine—Tachycardia—Doxorubicin—thyroid cancer	0.000176	0.00206	CcSEcCtD
Cimetidine—Somnolence—Epirubicin—thyroid cancer	0.000173	0.00203	CcSEcCtD
Cimetidine—Fatigue—Epirubicin—thyroid cancer	0.000168	0.00197	CcSEcCtD
Cimetidine—ABCB1—thyroid gland—thyroid cancer	0.000167	0.0075	CbGeAlD
Cimetidine—Constipation—Epirubicin—thyroid cancer	0.000166	0.00195	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000164	0.00192	CcSEcCtD
Cimetidine—Feeling abnormal—Epirubicin—thyroid cancer	0.00016	0.00188	CcSEcCtD
Cimetidine—Somnolence—Doxorubicin—thyroid cancer	0.00016	0.00188	CcSEcCtD
Cimetidine—Fatigue—Doxorubicin—thyroid cancer	0.000155	0.00182	CcSEcCtD
Cimetidine—Constipation—Doxorubicin—thyroid cancer	0.000154	0.00181	CcSEcCtD
Cimetidine—Body temperature increased—Epirubicin—thyroid cancer	0.000154	0.0018	CcSEcCtD
Cimetidine—ABCB1—head—thyroid cancer	0.000149	0.00665	CbGeAlD
Cimetidine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000148	0.00174	CcSEcCtD
Cimetidine—Hypersensitivity—Epirubicin—thyroid cancer	0.000143	0.00168	CcSEcCtD
Cimetidine—Body temperature increased—Doxorubicin—thyroid cancer	0.000142	0.00167	CcSEcCtD
Cimetidine—Asthenia—Epirubicin—thyroid cancer	0.00014	0.00164	CcSEcCtD
Cimetidine—Diarrhoea—Epirubicin—thyroid cancer	0.000133	0.00156	CcSEcCtD
Cimetidine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000133	0.00156	CcSEcCtD
Cimetidine—Asthenia—Doxorubicin—thyroid cancer	0.000129	0.00152	CcSEcCtD
Cimetidine—Dizziness—Epirubicin—thyroid cancer	0.000129	0.00151	CcSEcCtD
Cimetidine—Vomiting—Epirubicin—thyroid cancer	0.000124	0.00145	CcSEcCtD
Cimetidine—Diarrhoea—Doxorubicin—thyroid cancer	0.000123	0.00145	CcSEcCtD
Cimetidine—Rash—Epirubicin—thyroid cancer	0.000123	0.00144	CcSEcCtD
Cimetidine—Dermatitis—Epirubicin—thyroid cancer	0.000123	0.00144	CcSEcCtD
Cimetidine—Headache—Epirubicin—thyroid cancer	0.000122	0.00143	CcSEcCtD
Cimetidine—Dizziness—Doxorubicin—thyroid cancer	0.000119	0.0014	CcSEcCtD
Cimetidine—Nausea—Epirubicin—thyroid cancer	0.000116	0.00136	CcSEcCtD
Cimetidine—Vomiting—Doxorubicin—thyroid cancer	0.000114	0.00134	CcSEcCtD
Cimetidine—Rash—Doxorubicin—thyroid cancer	0.000113	0.00133	CcSEcCtD
Cimetidine—Dermatitis—Doxorubicin—thyroid cancer	0.000113	0.00133	CcSEcCtD
Cimetidine—Headache—Doxorubicin—thyroid cancer	0.000113	0.00132	CcSEcCtD
Cimetidine—Nausea—Doxorubicin—thyroid cancer	0.000107	0.00125	CcSEcCtD
Cimetidine—ABCB1—lymph node—thyroid cancer	0.000104	0.00466	CbGeAlD
Cimetidine—SLC22A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.19e-05	0.00106	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—MINPP1—thyroid cancer	4.18e-05	0.00105	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—SST—thyroid cancer	4.17e-05	0.00105	CbGpPWpGaD
Cimetidine—SLC22A8—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.13e-05	0.00104	CbGpPWpGaD
Cimetidine—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.1e-05	0.00103	CbGpPWpGaD
Cimetidine—CYP2D6—Biological oxidations—RXRA—thyroid cancer	4.05e-05	0.00102	CbGpPWpGaD
Cimetidine—CYP2C9—Biological oxidations—RXRA—thyroid cancer	4.01e-05	0.00101	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—CALCA—thyroid cancer	4.01e-05	0.00101	CbGpPWpGaD
Cimetidine—SLC22A1—Transmission across Chemical Synapses—BRAF—thyroid cancer	3.99e-05	0.00101	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—SLC5A5—thyroid cancer	3.96e-05	0.000998	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	3.95e-05	0.000996	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.88e-05	0.000978	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	3.81e-05	0.00096	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—HPGD—thyroid cancer	3.73e-05	0.00094	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—HPGD—thyroid cancer	3.72e-05	0.000938	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	3.64e-05	0.000919	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—CDK1—thyroid cancer	3.63e-05	0.000915	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—MINPP1—thyroid cancer	3.62e-05	0.000913	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—NDUFA13—thyroid cancer	3.56e-05	0.000898	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—NDUFA13—thyroid cancer	3.56e-05	0.000896	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—HPGD—thyroid cancer	3.47e-05	0.000875	CbGpPWpGaD
Cimetidine—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.44e-05	0.000868	CbGpPWpGaD
Cimetidine—CYP1A2—Biological oxidations—RXRA—thyroid cancer	3.43e-05	0.000864	CbGpPWpGaD
Cimetidine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.42e-05	0.000861	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—TPR—thyroid cancer	3.41e-05	0.000859	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PRKAR1A—thyroid cancer	3.35e-05	0.000845	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—CHST14—thyroid cancer	3.35e-05	0.000845	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—CHST14—thyroid cancer	3.34e-05	0.000843	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—RXRA—thyroid cancer	3.33e-05	0.000839	CbGpPWpGaD
Cimetidine—SLC22A2—Neuronal System—BRAF—thyroid cancer	3.28e-05	0.000828	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	3.28e-05	0.000826	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—TPR—thyroid cancer	3.27e-05	0.000824	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—SLC5A5—thyroid cancer	3.26e-05	0.000821	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—MINPP1—thyroid cancer	3.23e-05	0.000815	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PRKAR1A—thyroid cancer	3.21e-05	0.000811	CbGpPWpGaD
Cimetidine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.18e-05	0.000803	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—TSHR—thyroid cancer	3.16e-05	0.000798	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—MINPP1—thyroid cancer	3.16e-05	0.000796	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PRKAR1A—thyroid cancer	3.11e-05	0.000785	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—NDUFA13—thyroid cancer	3.08e-05	0.000776	CbGpPWpGaD
Cimetidine—SLC22A1—Neuronal System—BRAF—thyroid cancer	3.06e-05	0.000772	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.05e-05	0.000769	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MEN1—thyroid cancer	2.98e-05	0.00075	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—MINPP1—thyroid cancer	2.97e-05	0.00075	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—MINPP1—thyroid cancer	2.95e-05	0.000743	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—PPARG—thyroid cancer	2.94e-05	0.000741	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.91e-05	0.000735	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—CHST14—thyroid cancer	2.9e-05	0.00073	CbGpPWpGaD
Cimetidine—SLC22A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.87e-05	0.000724	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	2.78e-05	0.000702	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—NDUFA13—thyroid cancer	2.75e-05	0.000693	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—RXRA—thyroid cancer	2.74e-05	0.00069	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—HPGD—thyroid cancer	2.7e-05	0.000681	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—HPGD—thyroid cancer	2.69e-05	0.000679	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PTCH1—thyroid cancer	2.69e-05	0.000678	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—NDUFA13—thyroid cancer	2.68e-05	0.000676	CbGpPWpGaD
Cimetidine—SLC22A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.68e-05	0.000675	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.66e-05	0.000671	CbGpPWpGaD
Cimetidine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	2.65e-05	0.000667	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—CHST14—thyroid cancer	2.58e-05	0.000652	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—SLC5A5—thyroid cancer	2.55e-05	0.000643	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—NDUFA13—thyroid cancer	2.53e-05	0.000637	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—CHST14—thyroid cancer	2.52e-05	0.000636	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—MINPP1—thyroid cancer	2.52e-05	0.000635	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—NDUFA13—thyroid cancer	2.51e-05	0.000632	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	2.49e-05	0.000629	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	2.49e-05	0.000629	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—SST—thyroid cancer	2.46e-05	0.000621	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.45e-05	0.000618	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—SLC5A5—thyroid cancer	2.45e-05	0.000617	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—CHST14—thyroid cancer	2.38e-05	0.000599	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CALCA—thyroid cancer	2.37e-05	0.000597	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—CHST14—thyroid cancer	2.36e-05	0.000594	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—HPGD—thyroid cancer	2.33e-05	0.000588	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—PTGS2—thyroid cancer	2.31e-05	0.000583	CbGpPWpGaD
Cimetidine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	2.31e-05	0.000582	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.29e-05	0.000578	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CDK1—thyroid cancer	2.14e-05	0.000541	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—RXRA—thyroid cancer	2.14e-05	0.00054	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—NDUFA13—thyroid cancer	2.14e-05	0.00054	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—TPR—thyroid cancer	2.14e-05	0.00054	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—TPR—thyroid cancer	2.14e-05	0.000539	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	2.11e-05	0.000531	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PRKAR1A—thyroid cancer	2.1e-05	0.00053	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—PPARG—thyroid cancer	2.1e-05	0.00053	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—HPGD—thyroid cancer	2.08e-05	0.000525	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—RXRA—thyroid cancer	2.06e-05	0.000518	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—HPGD—thyroid cancer	2.03e-05	0.000513	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—PTEN—thyroid cancer	2.02e-05	0.000508	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—CHST14—thyroid cancer	2.01e-05	0.000508	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2e-05	0.000504	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—TPR—thyroid cancer	1.99e-05	0.000502	CbGpPWpGaD
Cimetidine—SLC22A2—Transmission across Chemical Synapses—HRAS—thyroid cancer	1.97e-05	0.000497	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.96e-05	0.000495	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PRKAR1A—thyroid cancer	1.96e-05	0.000494	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—MINPP1—thyroid cancer	1.94e-05	0.00049	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—HPGD—thyroid cancer	1.92e-05	0.000483	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—HPGD—thyroid cancer	1.9e-05	0.000479	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.89e-05	0.000477	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.87e-05	0.000471	CbGpPWpGaD
Cimetidine—SLC22A1—Transmission across Chemical Synapses—HRAS—thyroid cancer	1.84e-05	0.000463	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.77e-05	0.000447	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—PPARG—thyroid cancer	1.73e-05	0.000436	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—NRG1—thyroid cancer	1.72e-05	0.000434	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.71e-05	0.000431	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.69e-05	0.000426	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.65e-05	0.000417	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—PTGS2—thyroid cancer	1.65e-05	0.000417	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—HPGD—thyroid cancer	1.62e-05	0.000409	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—SLC5A5—thyroid cancer	1.6e-05	0.000404	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—SLC5A5—thyroid cancer	1.6e-05	0.000403	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.57e-05	0.000395	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CHST14—thyroid cancer	1.55e-05	0.000392	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—TPR—thyroid cancer	1.55e-05	0.000391	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—TPR—thyroid cancer	1.55e-05	0.00039	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—TERT—thyroid cancer	1.55e-05	0.00039	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.54e-05	0.000388	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	1.53e-05	0.000385	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	1.52e-05	0.000384	CbGpPWpGaD
Cimetidine—SLC22A2—Neuronal System—HRAS—thyroid cancer	1.51e-05	0.000381	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—SLC5A5—thyroid cancer	1.49e-05	0.000376	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—HIF1A—thyroid cancer	1.48e-05	0.000373	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—PTEN—thyroid cancer	1.44e-05	0.000363	CbGpPWpGaD
Cimetidine—SLC22A1—Neuronal System—HRAS—thyroid cancer	1.41e-05	0.000355	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—PTGS2—thyroid cancer	1.36e-05	0.000343	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PPARG—thyroid cancer	1.35e-05	0.000341	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—RXRA—thyroid cancer	1.35e-05	0.00034	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—RXRA—thyroid cancer	1.34e-05	0.000339	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—TPR—thyroid cancer	1.34e-05	0.000338	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.32e-05	0.000332	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.32e-05	0.000332	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.31e-05	0.000331	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—NRAS—thyroid cancer	1.3e-05	0.000328	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PPARG—thyroid cancer	1.3e-05	0.000327	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—RXRA—thyroid cancer	1.25e-05	0.000316	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—HPGD—thyroid cancer	1.25e-05	0.000316	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—BRAF—thyroid cancer	1.22e-05	0.000309	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—TPR—thyroid cancer	1.2e-05	0.000302	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.2e-05	0.000301	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—PTEN—thyroid cancer	1.19e-05	0.000299	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.18e-05	0.000297	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—TPR—thyroid cancer	1.17e-05	0.000294	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.17e-05	0.000294	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—AKT1—thyroid cancer	1.16e-05	0.000293	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—SLC5A5—thyroid cancer	1.16e-05	0.000293	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.16e-05	0.000292	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.15e-05	0.00029	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—KRAS—thyroid cancer	1.12e-05	0.000283	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—TPR—thyroid cancer	1.1e-05	0.000277	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—TPR—thyroid cancer	1.09e-05	0.000275	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.08e-05	0.000273	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.07e-05	0.000271	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.07e-05	0.000269	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PTGS2—thyroid cancer	1.06e-05	0.000268	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PTGS2—thyroid cancer	1.02e-05	0.000257	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1e-05	0.000253	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	9.86e-06	0.000249	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—RXRA—thyroid cancer	9.75e-06	0.000246	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—RXRA—thyroid cancer	9.73e-06	0.000245	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.73e-06	0.000245	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—HRAS—thyroid cancer	9.53e-06	0.00024	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.4e-06	0.000237	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—TPR—thyroid cancer	9.32e-06	0.000235	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PTEN—thyroid cancer	9.29e-06	0.000234	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—AKT1—thyroid cancer	9.26e-06	0.000234	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	9.17e-06	0.000231	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—SLC5A5—thyroid cancer	8.96e-06	0.000226	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CCND1—thyroid cancer	8.93e-06	0.000225	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PTEN—thyroid cancer	8.9e-06	0.000224	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—SLC5A5—thyroid cancer	8.74e-06	0.00022	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PTEN—thyroid cancer	8.62e-06	0.000217	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PPARG—thyroid cancer	8.5e-06	0.000214	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PPARG—thyroid cancer	8.49e-06	0.000214	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—RXRA—thyroid cancer	8.43e-06	0.000213	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—AKT1—thyroid cancer	8.41e-06	0.000212	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.39e-06	0.000212	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.31e-06	0.00021	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—AKT1—thyroid cancer	8.3e-06	0.000209	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	8.24e-06	0.000208	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.2e-06	0.000207	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—SLC5A5—thyroid cancer	8.17e-06	0.000206	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PPARG—thyroid cancer	7.91e-06	0.000199	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—NRAS—thyroid cancer	7.69e-06	0.000194	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.65e-06	0.000193	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—RXRA—thyroid cancer	7.53e-06	0.00019	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—RXRA—thyroid cancer	7.35e-06	0.000185	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.32e-06	0.000185	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—TPR—thyroid cancer	7.2e-06	0.000181	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	7.08e-06	0.000178	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	6.98e-06	0.000176	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—RXRA—thyroid cancer	6.92e-06	0.000175	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—RXRA—thyroid cancer	6.86e-06	0.000173	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—AKT1—thyroid cancer	6.83e-06	0.000172	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PTGS2—thyroid cancer	6.69e-06	0.000169	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PTGS2—thyroid cancer	6.68e-06	0.000168	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.67e-06	0.000168	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—KRAS—thyroid cancer	6.62e-06	0.000167	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.54e-06	0.000165	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PTGS2—thyroid cancer	6.22e-06	0.000157	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PPARG—thyroid cancer	6.16e-06	0.000155	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PPARG—thyroid cancer	6.15e-06	0.000155	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—TP53—thyroid cancer	5.88e-06	0.000148	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—RXRA—thyroid cancer	5.86e-06	0.000148	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PTEN—thyroid cancer	5.83e-06	0.000147	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PTEN—thyroid cancer	5.82e-06	0.000147	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.7e-06	0.000144	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—HRAS—thyroid cancer	5.63e-06	0.000142	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PTEN—thyroid cancer	5.43e-06	0.000137	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	5.39e-06	0.000136	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—AKT1—thyroid cancer	5.35e-06	0.000135	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PPARG—thyroid cancer	5.32e-06	0.000134	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—AKT1—thyroid cancer	5.13e-06	0.000129	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—AKT1—thyroid cancer	4.97e-06	0.000125	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PTGS2—thyroid cancer	4.84e-06	0.000122	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PTGS2—thyroid cancer	4.83e-06	0.000122	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PPARG—thyroid cancer	4.75e-06	0.00012	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PPARG—thyroid cancer	4.64e-06	0.000117	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—RXRA—thyroid cancer	4.53e-06	0.000114	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PPARG—thyroid cancer	4.37e-06	0.00011	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PPARG—thyroid cancer	4.33e-06	0.000109	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PTEN—thyroid cancer	4.23e-06	0.000107	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PTEN—thyroid cancer	4.22e-06	0.000106	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PTGS2—thyroid cancer	4.19e-06	0.000106	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PTGS2—thyroid cancer	3.74e-06	9.42e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PPARG—thyroid cancer	3.7e-06	9.33e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PTEN—thyroid cancer	3.65e-06	9.21e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PTGS2—thyroid cancer	3.65e-06	9.2e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PTGS2—thyroid cancer	3.44e-06	8.67e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PTGS2—thyroid cancer	3.41e-06	8.59e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—AKT1—thyroid cancer	3.36e-06	8.48e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—AKT1—thyroid cancer	3.36e-06	8.46e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PTEN—thyroid cancer	3.26e-06	8.22e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PTEN—thyroid cancer	3.18e-06	8.02e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—AKT1—thyroid cancer	3.13e-06	7.89e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PTEN—thyroid cancer	3e-06	7.56e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PTEN—thyroid cancer	2.97e-06	7.49e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PTGS2—thyroid cancer	2.91e-06	7.34e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PPARG—thyroid cancer	2.86e-06	7.2e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PTEN—thyroid cancer	2.54e-06	6.4e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—AKT1—thyroid cancer	2.43e-06	6.14e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—AKT1—thyroid cancer	2.43e-06	6.13e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.25e-06	5.67e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—AKT1—thyroid cancer	2.1e-06	5.31e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PTEN—thyroid cancer	1.96e-06	4.94e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—AKT1—thyroid cancer	1.88e-06	4.74e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—AKT1—thyroid cancer	1.83e-06	4.62e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—AKT1—thyroid cancer	1.73e-06	4.36e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—AKT1—thyroid cancer	1.71e-06	4.32e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—AKT1—thyroid cancer	1.46e-06	3.69e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—AKT1—thyroid cancer	1.13e-06	2.85e-05	CbGpPWpGaD
